Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Bogner

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
HIV Medicine|September 1, 2017
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive peopleL Shepherd, Á H Borges, R Harvey, et al.
HIV Medicine|May 12, 2016
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisG Fätkenheuer, H Jessen, A Stoehr, et al.
Infection|September 17, 2013
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)J Thoden, A Potthoff, J R Bogner, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
HIV Medicine|September 1, 2017
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive peopleL Shepherd, Á H Borges, R Harvey, et al.
HIV Medicine|May 12, 2016
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisG Fätkenheuer, H Jessen, A Stoehr, et al.
Infection|September 17, 2013
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)J Thoden, A Potthoff, J R Bogner, et al.
Pageof 14